Featured Articles
 
 
WHO Suspends Hydroxychloroquine Study Arm of COVID-19 Solidarity Trial
New data showed that treatment with hydroxychloroquine was associated with increased mortality in hospitalized patients with COVID-19.
Read more
 
 
FDA Oks Octapharma’s IVIG to Begin Phase 3 Trial for Severe COVID-19
Officials with the FDA have approved Octapharma’s investigational new drug (IND) application for intravenous immune globulin (IVIG) (Human, Octagam 10%) therapy.
Read more
Read More
 
Evidence-Based Treatment for Pediatric Migraine Prevention
The Importance of Early Treatment for Shingles
Analysis: Women, Older Adults Underrepresented in Cholesterol Drug Trials
Drug Interaction Concerns for Potential COVID-19 Treatments